While Sarepta has now consented to the FDA’s request to stop selling Elevidys, the company’s brief standoff with the agency ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...

The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to ...

NEW YORK, July 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 ...

Judge scolds Justice Department for ‘refusal’ to detail deportation plans for Kilmar Abrego Garcia The Salvadoran national could be released from a Tennessee jail as soon as next Wednesday to ...

GREENBELT, Md. (AP) — A federal judge in Maryland scolded the Trump administration on Friday for its “utter refusal” to detail its deportation plans for Kilmar Abrego Garcia, including where ...